A larger randomized, placebo-controlled intervention trial (the SELECT study) in more than 35,000 middle-aged and selenium-replete men, randomized to receive selenium (in the form of selenomethionine, 200 g/day) and/or vitamin E supplementation, was halted because of concerns regarding an increased risk of type 2 diabetes mellitus with selenium and increased risk of prostate cancer with vitamin E (84, 85)
Int J Oncol 1997;10(2):367373
Given that peptide users today are self-selected and tend to be young and healthy, their response may not be translatable to the general patient population who may have more medical comorbidities, Frank said
Therapies 79(2):283295 Rezaee R, Momtazi AA, Monemi A, Sahebkar A (2017) Curcumin: a potentially powerful tool to reverse cisplatin-induced toxicity
Zayed M, Iohara K
The super-absorbent core of Anandi XL Sanitary Pads may help manage heavy flow while maintaining dryness and comfort